Teva, Glenmark enter deferred prosecution deal DOJ over price fixing
Teva Reports Second Quarter 2023 Financial Results | Business Wire
Teva Pharmaceutical Industries and opioid settlement: What to know
Pharma giant Teva looks to steady ship with new CEO in coming weeks - The Times of Israel
Teva plans massive layoffs; Overland Park office's future unclear - Kansas City Business Journal
Articles about Teva Pharmaceuticals, Inc.
Teva Reaches Tentative $4.25 Billion Settlement Over Opioids - The New York Times
Opioid maker Teva agrees to tentative $4.25 billion deal - The Washington Post
Sanofi and Teva to develop novel IBD treatment
New York court dismisses most of Teva claims against Mexican drugmakers - The Times of Israel
TEVA.N - | Stock Price & Latest News | Reuters
$300 million Teva bet: Will Norway's wealth fund and ION regret investing in the phar | Ctech
Teva reaches $126M opioid settlement with hospitals - Top Class Actions
Jury finds Teva Pharmaceuticals fueled opioid epidemic in New York State
Teva stock pops on Q2 results, CEO sees 'significant' potential for trio of branded drugs
Why Is Teva Pharmaceuticals (TEVA) Stock Up Today? | InvestorPlace
Yahoo Finance on X: "$TEVA “has a strong future,” Teva Pharmaceuticals CEO Richard Francis says on Q2 earnings. “It's important that we keep delivering these numbers.” https://t.co/V7MDGVpXMy" / X
/arc-anglerfish-arc2-prod-pmn.s3.amazonaws.com/public/QLOB6IH57ZGW3NM55HWQDLO2BU.jpg "Teva Pharmaceutical Industries names a new CEO")
Teva Pharmaceutical Industries names a new CEO
Teva 'Plagued By Problems,' Downgraded On Lost MS Drug Patents, DOJ Probe | Stock News & Stock Market Analysis - IBD
Here's Why Teva Pharma Stock Is Soaring Today
Teva Pharmaceuticals: Israeli drugmaker to cut 14,000 jobs - BBC News
The best Teva sandals to wear this summer
Teva settlement prevents Lupin from launching its Austedo generic until 2033 | Fierce Pharma
Teva Pharmaceuticals found liable in New York opioid trial - BBC News
Articles about Teva Pharmaceuticals
Teva Pharmaceuticals Europe | Amsterdam
Teva shares plunge as competitors get nod for copycat flagship drug - The Times of Israel
